Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Peter Illei

Peter Bela Illei, MD

Director of Immunopathology Laboratory
Assistant Professor of Pathology
Male
Appointment Phone

410-955-1180

Main Location

The Johns Hopkins Hospital

View All Locations
Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-0773 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Director of Immunopathology Laboratory
  • Assistant Professor of Pathology

Centers & Institutes

  • Comprehensive Transplant Center

Expertise

Pathology, Pathology and Laboratory Medicine, Pulmonary Pathology, Transplant Pathology

Research Interests

Development of novel immunohistochemichal and molecular markers for the diagnosis of solid tissue tumors; Pathology of lung cancer; Pathology of lung transplantation; Pathology of thymic neoplasms

Biography

Dr. Peter Bela Illei is an assistant professor of pathology in the Division of Surgical Pathology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pathology and laboratory medicine, pulmonary pathology, and transplant pathology. Dr. Illei is the director of the Immunopathology Laboratory.

Dr. Illei earned his medical degree from University Pécs Medical School. He completed his residency at New York University Medical Center in pathology and performed a fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center.

Dr. Illei’s research interests include development of novel immunohistochemichal and molecular markers for the diagnosis of solid tissue tumors, pathology of lung cancer, pathology of lung transplantation, and pathology of thymic neoplasms.

Dr. Illei received the Pulmonary Pathology Society First Prize at the 91st Annual Meeting of the United States and Canadian Academy of Pathology.

Languages

  • English
  • Hungarian
  • German

Memberships

IASLC
Pulmonary Pathology Society
US-Canadian Academy of Pathology
College of American Pathologist

Additional Resources

Additional Resources +
  • Education +

    Training

    • University of Pecs Medical School (Pecs ) (1988)

    Residencies

    • New York University Medical Center / Pathology - Anatomic & Clinical (New York NY) (1998)

    Fellowships

    • Memorial Sloan - Kettering Cancer Center (New York NY) (2002)
    • Memorial Sloan - Kettering Cancer Center / Oncologic Pathology (New York NY) (2000)

    Certifications

    • American Board of Pathology / Clinical Pathology (2006)
    • American Board of Pathology / Cytopathology (2001)
    • American Board of Pathology / Anatomic Pathology (2000)
  • Research & Publications +

    Research Summary

    Dr. Illei’s research focuses on the immunohistochemichal and molecular characterization of lung cancers. His team is focused on developing novel tests to accurately categorize non-small cell carcinoma of the lung as well as new prognostic and therapeutic markers.

    Additional research interests include the role of antibody-mediated rejection in lung transplants, immunohistochemical profiling of thymic epithelial neoplasms and the role of rapid tissue processing and rapid automated immunohistochemistry in large tertiary care facilities.

    Selected Publications

    1. 1. Karanjawala ZE, Illei PB, Ashfaq R, Infante JR, Murphy K, Pandey A, Schulick R, Winter J, Sharma R, Maitra A, Goggins M, Hruban RH New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol. 2008 Feb;32(2):188-96.
    2. Sheridan T, Herawi M, Epstein JI, Illei PB. The Role of P501S and PSA in the Diagnosis of Metastatic Adenocarcinoma of the Prostate. Am J Surg Pathol. 2007 Sep;31(9):1351-5.
    3. Salaria SN, Illei P, Sharma R, Walter KM, Klein AP, Eshleman JR, Maitra A, Schulick R, Winter J, Ouellette MM, Goggins M, Hruban R. Palladin is Overexpressed in the Non-Neoplastic Stroma of Infiltrating Ductal Adenocarcinomas of the Pancreas, but is only Rarely Overexpressed in Neoplastic Cells. Cancer Biol Ther. 2007 Mar;6(3):324-8. Epub 2007 Mar 24
    4. Shimada S, Tsuzuki T, Kuroda M, Nagasaka T, Hara K, Takahashi E, Hayakawa S, Ono K, Maeda N, Mori N, Illei PB. Nestin expression as a new marker in malignant peripheral nerve sheath tumors. Pathol Int. 2007 Feb;57(2):60-7
    5. Lopez-Rios F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006 Mar 15;66(6):2970-9.
    6. Shia J, Qin J, Erlandson RA, King R, Illei P, Nobrega J, Yao D, Klimstra DS. Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases. Virchows Arch. 2005 Jul 14:1-7.
    7. Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, Healye JH, Gorlick R, Meyers P, and Ladanyi M. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol. 2005 Jan 20;23(3):548-58.
    8. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M: Multiple lines of evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive SV40 PCR results due to presence of SV40 sequences in common laboratory plasmids. Lancet, 2004 Sep 25, 364: 1157-1166.
    9. Illei PB, Rusch V, Zakowski MF, Ladanyi M: Homozygous Deletion of CDKN2A and Co-Deletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas. Clin Can Res, 2003 Jun;9(6):2108-
    10. Uren A, Merchant MS, Sun CJ, Vitolo M, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA: Beta-platelet-derived growth factor receptor mediates motility and growth of Ewings sarcoma cells. Oncogene, 2003 Apr 17;22(15):2334-42.
    11. Illei PB, Ladanyi M, Rusch V, Zakowski M: The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 2003 Feb 25;99(1):51-6.
    12. Illei PB, Rosai J, Klimstra DS: Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung. Arch Pathol Lab Med, 125:1335-1339, 2001.
  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    Pulmonary Pathology Society First Prize, 91st Annual Meeting, United States and Canadian Academy of Pathology, 2002

    Poster Award, International Congress of the International Academy of Pathology, 1996

    First Prize Young Clinical Investigator, Postgraduate Medical School, 1990

  • Videos & Media +
  • Events +
  • Contact & Locations +

    Locations

    The Johns Hopkins Hospital
    600 N. Wolfe Street
    Hospital Main Entrance - Sheikh Zayed Tower
    Baltimore, MD 21287
    Phone: 410-955-1180
    Appointment Phone: 410-955-1180
    Fax: 410-614-9663
    Location Map

    Department/Division

    • Pathology

Is This You? Edit Profile

 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.